| RB | Retinoblastoma |
| CDK | Cyclin dependent kinase |
| CDK4/6i | Cyclin dependent kinase 4/6 inhibitors |
| PARPi | Poly (ADP-ribose) polymerase inhibitors |
| CIN | Chromosomal instability |
| BETi | Bromodomain and extraterminal domain inhibitors |
| DOX | Doxorubicin |
| STS | Soft tissue sarcoma |
| PFS | Progression free survival |
| TNBC | Triple negative breast cancer |
| DREAM | Dimerization partner, RB-like, E2F, and the multi-vulval class B |
| HDACs | Histone deacetylases |
| CHR | Cell-cycle gene homology regions |
| ESC | Embryonic stem cell |
| CSC | Cancer stem cells |
| EMT | Epithelial-mesenchymal transition |
| DSB | Double-strand breaks |
| NHEJ | Non-homologous end joining |
| HR | Homologous recombination |
| ER | Estrogen receptor |
| 5-FU | 5-Fluorouracil |
| CRISPR | Clustered regularly interspaced short palindromic repeats |